BioCentury
ARTICLE | Company News

Endorex to acquire Corporate Technology Development

August 1, 2001 7:00 AM UTC

DOR will acquire specialty pharmaceutical company Corporate Technology Development (Miami, Fla.) in a stock-for-stock merger. Corporate Technology's orBec, a dual-release formulation of the corticoste...